Literature DB >> 24859925

A tailored implementation strategy to reduce the duration of intravenous antibiotic treatment in community-acquired pneumonia: a controlled before-and-after study.

M F Engel1, A H W Bruns, M E J L Hulscher, C A J M Gaillard, S U C Sankatsing, F Teding van Berkhout, M H Emmelot-Vonk, E M Kuck, M H M Steeghs, J H den Breeijen, R K Stellato, A I M Hoepelman, J J Oosterheert.   

Abstract

We previously showed that 40 % of clinically stable patients hospitalised for community-acquired pneumonia (CAP) are not switched to oral therapy in a timely fashion because of physicians' barriers. We aimed to decrease this proportion by implementing a novel protocol. In a multi-centre controlled before-and-after study, we evaluated the effect of an implementation strategy tailored to previously identified barriers to an early switch. In three Dutch hospitals, a protocol dictating a timely switch strategy was implemented using educational sessions, pocket reminders and active involvement of nursing staff. Primary outcomes were the proportion of patients switched timely and the duration of intravenous antibiotic therapy. Length of hospital stay (LOS), patient outcome, education effects 6 months after implementation and implementation costs were secondary outcomes. Statistical analysis was performed using mixed-effects models. Prior to implementation, 146 patients were included and, after implementation, 213 patients were included. The case mix was comparable. The implementation did not change the proportion of patients switched on time (66 %). The median duration of intravenous antibiotic administration decreased from 4 days [interquartile range (IQR) 2-5] to 3 days (IQR 2-4), a decrease of 21 % [95 % confidence interval (CI) 11 %; 30 %) in the multi-variable analysis. LOS and patient outcome were comparable before and after implementation. Forty-three percent (56/129) of physicians attended the educational sessions. After 6 months, 24 % (10/42) of the interviewed attendees remembered the protocol's main message. Cumulative implementation costs were <euro>5,798 (<euro>20/reduced intravenous treatment day). An implementation strategy tailored to previously identified barriers reduced the duration of intravenous antibiotic administration in hospitalised CAP patients by 1 day, at minimal cost.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859925     DOI: 10.1007/s10096-014-2158-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  29 in total

1.  Research designs for studies evaluating the effectiveness of change and improvement strategies.

Authors:  M Eccles; J Grimshaw; M Campbell; C Ramsay
Journal:  Qual Saf Health Care       Date:  2003-02

2.  Impact of an antimicrobial stewardship intervention on shortening the duration of therapy for community-acquired pneumonia.

Authors:  Edina Avdic; Lisa A Cushinotto; Andrew H Hughes; Amanda R Hansen; Leigh E Efird; John G Bartlett; Sara E Cosgrove
Journal:  Clin Infect Dis       Date:  2012-04-10       Impact factor: 9.079

3.  SWAB/NVALT (Dutch Working Party on Antibiotic Policy and Dutch Association of Chest Physicians) guidelines on the management of community-acquired pneumonia in adults.

Authors:  W J Wiersinga; M J Bonten; W G Boersma; R E Jonkers; R M Aleva; B J Kullberg; J A Schouten; J E Degener; R Janknegt; T J Verheij; A P E Sachs; J M Prins
Journal:  Neth J Med       Date:  2012-03       Impact factor: 1.422

4.  Economic benefit of a 1-day reduction in hospital stay for community-acquired pneumonia (CAP).

Authors:  C M Kozma; M Dickson; M K Raut; S Mody; A C Fisher; J R Schein; J I Mackowiak
Journal:  J Med Econ       Date:  2010-11-22       Impact factor: 2.448

5.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

6.  Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP.

Authors:  Madelon F Engel; Douwe F Postma; Marlies E J L Hulscher; Ferdinand Teding van Berkhout; Marielle H Emmelot-Vonk; Sanjay Sankatsing; Carlo A J M Gaillard; Anke H W Bruns; Andy I M Hoepelman; Jan Jelrik Oosterheert
Journal:  Eur Respir J       Date:  2012-05-31       Impact factor: 16.671

7.  Reaching stability in community-acquired pneumonia: the effects of the severity of disease, treatment, and the characteristics of patients.

Authors:  Rosario Menéndez; Antoni Torres; Felipe Rodríguez de Castro; Rafael Zalacaín; Javier Aspa; Juan J Martín Villasclaras; Luis Borderías; José M Benítez Moya; Juan Ruiz-Manzano; José Blanquer; Diego Pérez; Carmen Puzo; Fernando Sánchez-Gascón; José Gallardo; Carlos J Alvarez; Luis Molinos
Journal:  Clin Infect Dis       Date:  2004-11-18       Impact factor: 9.079

8.  Implementation of an evidence-based guideline to reduce duration of intravenous antibiotic therapy and length of stay for patients hospitalized with community-acquired pneumonia: a randomized controlled trial.

Authors:  Michael J Fine; Roslyn A Stone; Judith R Lave; Linda J Hough; D Scott Obrosky; Maria K Mor; Wishwa N Kapoor
Journal:  Am J Med       Date:  2003-10-01       Impact factor: 4.965

Review 9.  Interventions to improve antibiotic prescribing practices for hospital inpatients.

Authors:  Peter Davey; Erwin Brown; Esmita Charani; Lynda Fenelon; Ian M Gould; Alison Holmes; Craig R Ramsay; Philip J Wiffen; Mark Wilcox
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.

Authors:  J A Ramirez; L Srinath; S Ahkee; A Huang; M J Raff
Journal:  Arch Intern Med       Date:  1995-06-26
View more
  5 in total

Review 1.  South African guideline for the management of community-acquired pneumonia in adults.

Authors:  Tom H Boyles; Adrian Brink; Greg L Calligaro; Cheryl Cohen; Keertan Dheda; Gary Maartens; Guy A Richards; Richard van Zyl Smit; Clifford Smith; Sean Wasserman; Andrew C Whitelaw; Charles Feldman
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

Review 2.  Scoping review of costs of implementation strategies in community, public health and healthcare settings.

Authors:  Tzeyu L Michaud; Emiliane Pereira; Gwenndolyn Porter; Caitlin Golden; Jennie Hill; Jungyoon Kim; Hongmei Wang; Cindy Schmidt; Paul A Estabrooks
Journal:  BMJ Open       Date:  2022-06-28       Impact factor: 3.006

3.  Implementation strategies to promote measurement-based care in schools: evidence from mental health experts across the USA.

Authors:  Elizabeth H Connors; Aaron R Lyon; Kaylyn Garcia; Corianna E Sichel; Sharon Hoover; Mark D Weist; Jacob K Tebes
Journal:  Implement Sci Commun       Date:  2022-06-21

4.  Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.

Authors:  Raquel K Belforti; Tara Lagu; Sarah Haessler; Peter K Lindenauer; Penelope S Pekow; Aruna Priya; Marya D Zilberberg; Daniel Skiest; Thomas L Higgins; Mihaela S Stefan; Michael B Rothberg
Journal:  Clin Infect Dis       Date:  2016-04-05       Impact factor: 9.079

Review 5.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.